Skip to main content
Top
Published in: BMC Pulmonary Medicine 1/2006

Open Access 01-12-2006 | Research article

The relationship between stage 1 and 2 non-small cell lung cancer and lung function in men and women

Authors: Samir Malhotra, Stephen Lam, SF Paul Man, Wen Q Gan, Don D Sin

Published in: BMC Pulmonary Medicine | Issue 1/2006

Login to get access

Abstract

Background

Reduced forced expiratory volume in one second (FEV1) has been linked to non small cell lung cancer (NSCLC). However, it is unclear whether all or only certain histological subtypes of NSCLC are associated with reduced FEV1. Moreover, there is little information on whether gender modifies this relationship. Using a large tissue registry, we sought to determine the relationship between FEV1 and subtypes of NSCLC and determine whether this relationship is modified by gender.

Methods

We used data from patients who underwent tumor resection for NSCLC at a teaching hospital in Vancouver and had various pre-operative clinical measurements including FEV1. We divided the cohort into quartiles of predicted FEV1 and using both logistic and linear regression modeling techniques determined whether FEV1 was related to the occurrence of adeno or squamous cell carcinoma in men and women.

Results

There were 610 patients in the study (36% females). On average, women were more likely to have adenocarcinoma than were men (72% of all cases of NSCLC in women versus 40% in men; p < 0.001). In women, there was no significant relationship between FEV1 and the risk of any histological subtypes of NSCLC. In men, however, there was an inverse relationship between the risk of adenocarcinoma and FEV1 such that the lowest quartile of FEV1 was 47% less likely to have adenocarcinoma compared with the highest FEV1 quartile (adjusted odds ratio, 0.52; 0.28 to 0.98; p for trend, 0.028). The reverse was observed for squamous cell carcinoma.

Conclusion

In individuals undergoing lung resection for NSCLC, the risk of adenocarcinoma and squamous cell carcinoma of the lung varies as a function of FEV1, independent of smoking intensity in men but not in women.

Clinical Implications

These data indicate that women are much more susceptible to adenocarcinoma than are men especially when they have normal or near normal lung function. It may thus be useful to conduct periodic surveillance chest radiographs in asymptomatic female smokers (or ex-smokers) to ascertain peripheral nodules or masses before distant metastases occur since adenocarcinomas tend to metastasize earlier in the disease course than squamous cell carcinomas.
Appendix
Available only for authorised users
Literature
1.
go back to reference Jemal A, Tiwari RC, Murray T, Ghafoor A, Samuels A, Ward E, Feuer EJ, Thun MJ: Cancer Statistics 2004. CA Cancer J Clin. 2004, 54: 8-29.CrossRefPubMed Jemal A, Tiwari RC, Murray T, Ghafoor A, Samuels A, Ward E, Feuer EJ, Thun MJ: Cancer Statistics 2004. CA Cancer J Clin. 2004, 54: 8-29.CrossRefPubMed
2.
go back to reference Alberg AJ, Samet JM: Epidemiology of Lung Cancer. Chest. 2003, 123 (1 Supp): 21S-49S. 10.1378/chest.123.1_suppl.21S.CrossRefPubMed Alberg AJ, Samet JM: Epidemiology of Lung Cancer. Chest. 2003, 123 (1 Supp): 21S-49S. 10.1378/chest.123.1_suppl.21S.CrossRefPubMed
3.
go back to reference Skillurd DM, Offord KP, Miller RD: Higher risk of lung cancer in chronic pulmonary disease: a prospective, matched, controlled study. Ann Intern Med. 1986, 105: 503-507.CrossRef Skillurd DM, Offord KP, Miller RD: Higher risk of lung cancer in chronic pulmonary disease: a prospective, matched, controlled study. Ann Intern Med. 1986, 105: 503-507.CrossRef
4.
go back to reference Tockman MS, Anthonisen NR, Wright EC, Donithan MG: Airways obstruction and the risk for lung cancer. Ann Intern Med. 1987, 106: 512-518.CrossRefPubMed Tockman MS, Anthonisen NR, Wright EC, Donithan MG: Airways obstruction and the risk for lung cancer. Ann Intern Med. 1987, 106: 512-518.CrossRefPubMed
5.
go back to reference Lange P, Nyboe J, Appleyard M, Jensen G, Schnohr P: Ventilatory function and chronic mucus hypersecretion as predictors of death from lung cancer. Am Rev Respir Dis. 1990, 141: 613-617.CrossRefPubMed Lange P, Nyboe J, Appleyard M, Jensen G, Schnohr P: Ventilatory function and chronic mucus hypersecretion as predictors of death from lung cancer. Am Rev Respir Dis. 1990, 141: 613-617.CrossRefPubMed
6.
go back to reference Wasswa-Kintu S, Gan WQ, Man SF, Pare PD, Sin DD: The relationship between reduced forced expiratory volume in one second and the risk of lung cancer: A systematic review and meta-analysis. Thorax. 2005, 60: 570-575. 10.1136/thx.2004.037135.CrossRefPubMedPubMedCentral Wasswa-Kintu S, Gan WQ, Man SF, Pare PD, Sin DD: The relationship between reduced forced expiratory volume in one second and the risk of lung cancer: A systematic review and meta-analysis. Thorax. 2005, 60: 570-575. 10.1136/thx.2004.037135.CrossRefPubMedPubMedCentral
7.
go back to reference World Health Organization: Histological Typing of Lung Tumours. 1981, Geneva, World Health Organization, 2 World Health Organization: Histological Typing of Lung Tumours. 1981, Geneva, World Health Organization, 2
8.
go back to reference American Thoracic Society Official Statement: Lung Function Testing: Selection of Reference Values and Interpretative Strategies. Am Rev Respir Dis. 1991, 144: 1202-1218.CrossRef American Thoracic Society Official Statement: Lung Function Testing: Selection of Reference Values and Interpretative Strategies. Am Rev Respir Dis. 1991, 144: 1202-1218.CrossRef
9.
go back to reference Crapo RO, Morris AH, Gardner RM: Reference spirometric values using techniques and equipment that meet ATS recommendations. Am Rev Respir Dis. 1981, 123: 659-664.PubMed Crapo RO, Morris AH, Gardner RM: Reference spirometric values using techniques and equipment that meet ATS recommendations. Am Rev Respir Dis. 1981, 123: 659-664.PubMed
10.
go back to reference Papi A, Casoni G, Caramori G, Guzzinati I, Boschetto P, Ravenna F, Calia N, Petruzzelli S, Corbetta L, Cavallesco G, Forini E, Saetta M, Ciaccia A, Fabbri LM: COPD increases the risk of squamous histological subtype in smokers who develop non-small cell lung carcinoma. Thorax. 2004, 59: 679-681. 10.1136/thx.2003.018291.CrossRefPubMedPubMedCentral Papi A, Casoni G, Caramori G, Guzzinati I, Boschetto P, Ravenna F, Calia N, Petruzzelli S, Corbetta L, Cavallesco G, Forini E, Saetta M, Ciaccia A, Fabbri LM: COPD increases the risk of squamous histological subtype in smokers who develop non-small cell lung carcinoma. Thorax. 2004, 59: 679-681. 10.1136/thx.2003.018291.CrossRefPubMedPubMedCentral
11.
go back to reference Kure EH, Ryberg D, Hewer A, Phillips DH, Skaug V, Baera R, Haugen A: p53 Mutations in lung tumours: relationship to gender and lung DNA adduct levels. Carcinogenesis. 1996, 17: 2201-2205.CrossRefPubMed Kure EH, Ryberg D, Hewer A, Phillips DH, Skaug V, Baera R, Haugen A: p53 Mutations in lung tumours: relationship to gender and lung DNA adduct levels. Carcinogenesis. 1996, 17: 2201-2205.CrossRefPubMed
12.
go back to reference Stabile LP, Davis AL, Gubish CT, Hopkins TM, Luketich JD, Christie N, Finkelstein S, Siegfried JM: Human non-small cell lung tumors and cells derived from normal lung express both estrogen receptors alpha and beta at AP1 sites. Science. 1997, 277: 1508-1510. 10.1126/science.277.5331.1508.CrossRef Stabile LP, Davis AL, Gubish CT, Hopkins TM, Luketich JD, Christie N, Finkelstein S, Siegfried JM: Human non-small cell lung tumors and cells derived from normal lung express both estrogen receptors alpha and beta at AP1 sites. Science. 1997, 277: 1508-1510. 10.1126/science.277.5331.1508.CrossRef
13.
go back to reference McLemore TL, Adelberg S, Liu MC, McMahon NA, Yu SJ, Hubbard WC, Czerwinski M, Wood TG, Storeng R, Lubet RA: Expression of CYPA1 gene in patients with lung cancer: evidence for cigarette smoke-induced gene expression in normal lung tissue and for altered gene regulation in primary pulmonary carcinomas. J Natl Cancer Inst. 1990, 82: 1333-1339.CrossRefPubMed McLemore TL, Adelberg S, Liu MC, McMahon NA, Yu SJ, Hubbard WC, Czerwinski M, Wood TG, Storeng R, Lubet RA: Expression of CYPA1 gene in patients with lung cancer: evidence for cigarette smoke-induced gene expression in normal lung tissue and for altered gene regulation in primary pulmonary carcinomas. J Natl Cancer Inst. 1990, 82: 1333-1339.CrossRefPubMed
14.
go back to reference Mollerup S, Ryberg D, Hewer A, Phillips DH, Haugen A: Sex differences in lung CYP1A1 expression and DNA adduct levels among lung cancer patients. Cancer Res. 1999, 59: 3317-3320.PubMed Mollerup S, Ryberg D, Hewer A, Phillips DH, Haugen A: Sex differences in lung CYP1A1 expression and DNA adduct levels among lung cancer patients. Cancer Res. 1999, 59: 3317-3320.PubMed
15.
go back to reference Ardies CM: Inflammation as a cause of scar cancers of the lung. Integrative Cancer Therapies. 2003, 3: 238-246. 10.1177/1534735403256332.CrossRef Ardies CM: Inflammation as a cause of scar cancers of the lung. Integrative Cancer Therapies. 2003, 3: 238-246. 10.1177/1534735403256332.CrossRef
16.
go back to reference Achiwa H, Yatabe Y, Hida T, Kuroishi T, Kozaki K, Nakamura S, Ogawa M, Sugiura T, Mitsudomi T, Takahashi T: Prognostic significance of elevated cyclooxygenase 2 expression in primary, resected lung adenocarcinomas. Clin Cancer Res. 1999, 5: 1001-1005.PubMed Achiwa H, Yatabe Y, Hida T, Kuroishi T, Kozaki K, Nakamura S, Ogawa M, Sugiura T, Mitsudomi T, Takahashi T: Prognostic significance of elevated cyclooxygenase 2 expression in primary, resected lung adenocarcinomas. Clin Cancer Res. 1999, 5: 1001-1005.PubMed
17.
go back to reference Ermert L, Dierkes C, Ermert M: Immunohistochemical expression of cyclooxygenase isoenzymes and downstream enzymes in human lung tumors. Clin Cancer Res. 2003, 9: 1604-1610.PubMed Ermert L, Dierkes C, Ermert M: Immunohistochemical expression of cyclooxygenase isoenzymes and downstream enzymes in human lung tumors. Clin Cancer Res. 2003, 9: 1604-1610.PubMed
18.
go back to reference Yao R, Rioux N, Castonguay A, You M: Inhibition of COX-2 and induction of apoptosis: two determinants of nonsteroidal anti-inflammatory drugs' chemopreventive efficacies in mouse lung tumorigenesis. Exp Lung Res. 2000, 26: 731-742. 10.1080/01902140150216783.CrossRefPubMed Yao R, Rioux N, Castonguay A, You M: Inhibition of COX-2 and induction of apoptosis: two determinants of nonsteroidal anti-inflammatory drugs' chemopreventive efficacies in mouse lung tumorigenesis. Exp Lung Res. 2000, 26: 731-742. 10.1080/01902140150216783.CrossRefPubMed
19.
go back to reference Folkman J: Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis. N Engl J Med. 1995, 333: 1757-1763. 10.1056/NEJM199512283332608.CrossRefPubMed Folkman J: Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis. N Engl J Med. 1995, 333: 1757-1763. 10.1056/NEJM199512283332608.CrossRefPubMed
20.
go back to reference Brabender J, Park J, Metzger R, Schneider PM, Lord RV, Holscher AH, Danenberg KD, Danenberg PV: Prognostic significance of cyclooxygenase 2 mRNA expression in non-small cell lung cancer. Ann Surg. 2002, 235: 440-443. 10.1097/00000658-200203000-00017.CrossRefPubMedPubMedCentral Brabender J, Park J, Metzger R, Schneider PM, Lord RV, Holscher AH, Danenberg KD, Danenberg PV: Prognostic significance of cyclooxygenase 2 mRNA expression in non-small cell lung cancer. Ann Surg. 2002, 235: 440-443. 10.1097/00000658-200203000-00017.CrossRefPubMedPubMedCentral
21.
go back to reference Szczeklik W, Sanak M, Szczeklik A: Functional effects and gender association of COX-2 gene polymorphism G-765C in bronchial asthma. J Allergy Clin Immunol. 2004, 114: 248-253. 10.1016/j.jaci.2004.05.030.CrossRefPubMed Szczeklik W, Sanak M, Szczeklik A: Functional effects and gender association of COX-2 gene polymorphism G-765C in bronchial asthma. J Allergy Clin Immunol. 2004, 114: 248-253. 10.1016/j.jaci.2004.05.030.CrossRefPubMed
22.
go back to reference Papafili A, Hill MR, Brull DJ, McAnulty RJ, Marshall RP, Humphries SE, Laurent GJ: Common promoter variant in cyclooxygenase-2 represses gene expression: evidence of role in acute-phase inflammatory response. Arterioscler Thromb Vasc Biol. 2002, 22: 1631-1636. 10.1161/01.ATV.0000030340.80207.C5.CrossRefPubMed Papafili A, Hill MR, Brull DJ, McAnulty RJ, Marshall RP, Humphries SE, Laurent GJ: Common promoter variant in cyclooxygenase-2 represses gene expression: evidence of role in acute-phase inflammatory response. Arterioscler Thromb Vasc Biol. 2002, 22: 1631-1636. 10.1161/01.ATV.0000030340.80207.C5.CrossRefPubMed
23.
go back to reference Van Winkle LS, Gunderson AD, Shimizu J, Baker GL, Brown CD: Gender differences in naphthalene metabolism and naphthalene induced lung-injury. Am J Physiol Lung Cell Mol Physiol. 2002, 282: L1122-L1134.CrossRefPubMed Van Winkle LS, Gunderson AD, Shimizu J, Baker GL, Brown CD: Gender differences in naphthalene metabolism and naphthalene induced lung-injury. Am J Physiol Lung Cell Mol Physiol. 2002, 282: L1122-L1134.CrossRefPubMed
Metadata
Title
The relationship between stage 1 and 2 non-small cell lung cancer and lung function in men and women
Authors
Samir Malhotra
Stephen Lam
SF Paul Man
Wen Q Gan
Don D Sin
Publication date
01-12-2006
Publisher
BioMed Central
Published in
BMC Pulmonary Medicine / Issue 1/2006
Electronic ISSN: 1471-2466
DOI
https://doi.org/10.1186/1471-2466-6-2

Other articles of this Issue 1/2006

BMC Pulmonary Medicine 1/2006 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.